Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
54.49B | 48.38B | 45.32B | 41.04B | 42.93B | Gross Profit |
13.68B | 12.24B | 11.46B | 9.79B | 9.35B | EBIT |
2.13B | 2.27B | 2.51B | 2.06B | 2.02B | EBITDA |
2.75B | 2.69B | 2.97B | 2.69B | 2.08B | Net Income Common Stockholders |
1.21B | 1.18B | 1.48B | 852.00M | 769.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.47B | 7.01B | 7.29B | 6.63B | 6.07B | Total Assets |
33.38B | 30.72B | 27.50B | 24.69B | 25.04B | Total Debt |
2.87B | 2.73B | 2.02B | 2.43B | 3.00B | Net Debt |
-4.60B | -4.28B | -5.26B | -4.20B | -3.07B | Total Liabilities |
20.16B | 18.23B | 16.11B | 14.82B | 15.81B | Stockholders Equity |
11.41B | 10.54B | 9.44B | 7.98B | 7.57B |
Cash Flow | Free Cash Flow | |||
1.36B | 1.34B | 1.75B | 1.65B | 2.96B | Operating Cash Flow |
1.52B | 1.59B | 2.23B | 1.92B | 3.09B | Investing Cash Flow |
-268.00M | -2.05B | -725.00M | -112.00M | -413.00M | Financing Cash Flow |
-813.00M | 56.00M | -871.00M | -1.24B | -338.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥197.36B | 10.50 | 2.68% | 5.04% | 40.52% | ||
73 Outperform | ¥9.16B | 16.65 | 1.97% | 11.65% | -50.43% | ||
72 Outperform | ¥54.67B | 14.24 | 1.92% | 7.87% | 18.69% | ||
70 Outperform | ¥121.54B | 33.75 | 1.83% | 6.03% | -41.79% | ||
67 Neutral | ¥288.75B | 51.71 | 0.58% | 7.27% | 10.84% | ||
60 Neutral | ¥180.48B | 47.26 | 1.44% | 0.99% | -48.66% | ||
59 Neutral | $13.74B | 7.33 | -2.74% | 3.82% | 2.18% | -37.91% |